Guinea-Bissau cancels controversial US-Funded hepatitis B vaccine trial

After weeks of back and forth, Guinea Bissau has cancelled a proposed vaccine trial on newborn babies over mounting criticism that it was unethical and exploitative.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.